martes, 18 de agosto de 2020

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1 | Journal of Experimental & Clinical Cancer Research | Full Text

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1 | Journal of Experimental & Clinical Cancer Research | Full Text

Chemoresistance is emerging as a major barrier to successful treatment in acute myeloid leukemia (AML), and evasion of apoptosis is among the fundamental underlying mechanisms. Therefore, unraveling molecular ...
Authors:Yihua Pang, Yanan Zhao, Yan Wang, Xinlu Wang, Ruiqing Wang, Na Liu, Peng Li, Min Ji, Jingjing Ye, Tao Sun, Jingxin Li, Daoxin Ma, Fei Lu and Chunyan Ji
Citation:Journal of Experimental & Clinical Cancer Research 2020 39:158
Content type:Research
 
Published on: 

No hay comentarios:

Publicar un comentario